E09.355
Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code E09.355 refers to a specific type of diabetes known as drug or chemical-induced diabetes mellitus, which is accompanied by stable proliferative diabetic retinopathy. This condition occurs when certain medications or chemicals cause blood sugar levels to rise, leading to diabetes, and is associated with a progressive damage to the blood vessels in the retina of the eye. The term 'stable' indicates that the proliferative diabetic retinopathy has not worsened recently. Recognizing and understanding this condition helps in managing and monitoring affected individuals effectively.
Causes & Symptoms
Clinical Causes: Use of certain medications such as corticosteroids, antipsychotics, or immunosuppressants Exposure to specific chemicals or toxins that interfere with insulin production or action Underlying susceptibility due to pre-existing health conditions or genetic factors
Key Symptoms: Elevated blood sugar levels Increased thirst and frequent urination Blurred vision Dark or fixed spots in the visual field Possible eye discomfort or redness No noticeable symptoms in early stages; often detected through screening
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of blood tests to measure blood glucose levels, hemoglobin A1c testing to assess long-term glucose control, and thorough eye examinations. The eye doctor looks for signs of proliferative diabetic retinopathy, such as abnormal blood vessels and bleeding into the retinal tissue. Medical history review focuses on medication or chemical exposure history to confirm drug or chemical-induced diabetes. Imaging techniques like fluorescein angiography may be used to visualize retinal blood vessels.
Treatment Protocols: Managing this condition involves controlling blood sugar levels through medication adjustments, lifestyle changes, and discontinuing or substituting offending drugs or chemicals when possible. For eye complications, treatments aim to prevent vision loss and include laser therapy, intravitreal injections of medications to reduce abnormal blood vessel growth, and regular eye monitoring. Addressing underlying causes and close collaboration between medical specialists are essential components of comprehensive care.
Clinical Advice & FAQs
Billing Guidance
Is E09.355 a billable ICD-10 code?
Yes, E09.355 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E09.355?
Clinical documentation must specify the nature of Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference